壳聚糖-阿拉伯胶布洛芬缓释微囊制备工艺研究

本文以壳聚糖和阿拉伯胶为囊材,利用复凝聚法将布洛芬微囊化。以微囊的药物包封率为制备工艺优化指标,通过正交实验得出微囊的最佳制备工艺条件为：壳聚糖浓度为0．2％、成囊pH为4．5、成囊温度为45℃、搅拌速度为200rpm。以最佳制备工艺条件制备含药微囊,重现性好,工艺稳定,同时体外溶出实验表明,该微囊具有较好的缓释作用。     

微胶囊化蒜粉的工艺研究

蒜粉微胶囊化工艺可以保护蒜粉中的生物活性物质不被破坏.本文研究了不同的工艺条件对微胶囊化蒜粉的产率和效率的影响.结果表明最佳工艺条件为:蒜粉粒径范围30～100目,EC壁材溶液浓度3%,心材与壁材比4∶ 1,壁材与聚乙二醇(PEG)比4∶ 1,此时微胶囊化产率和效率分别达到95%和96.8%.     

克雷伯氏杆菌的固定化及其在微胶囊中生长状况的研究

采用注滴法制备载克雷伯氏杆菌的海藻酸盐微胶囊,对微胶囊制备条件进行优化,并考察了各种因素对克雷伯氏杆菌微囊化的影响。实验结果表明：控制海藻酸钠溶液的质量分数为2%、氯化钙溶液的质量分数为4.5%、凝胶反应4 h以及菌体与海藻酸钠溶液体积比为1：30,所制备的微胶囊及微囊内菌体的生长效果最好。还初步探讨了壳聚糖对海藻酸盐微胶囊的影响,发现微胶囊表面复合一层壳聚糖半透膜,可以提高微胶囊的强度,但弹性有所降低。另外进行了微胶囊中克雷伯氏菌代谢途径的探索。     

粒径对微胶囊成膜及微囊化细胞生长代谢的影响

目的:考察粒径对微胶囊强度及微囊化细胞生长代谢的影响,为制备性能优良的生物微胶囊提供实验依据。方法:制备不同粒径的凝胶珠,测定其在相同成膜条件下的球磨强度,进而用台盘蓝拒染法测定微囊化细胞的增殖及活率。结果:小粒径的微胶囊具有更厚的微囊膜及更高的球磨强度,另外小粒径微胶囊培养细胞能够获得更多的细胞数(350μm,570μm和900μm微囊内的细胞数量分别为:5.67×107、4.71×107和3.89×107/mL microcapsule,P<0.05)及更高的细胞活率(350μm、570μm和900μm微胶囊的细胞活率分别为:83.70%、67.64%和75.73%,P<0.05)。结论:粒径能影响微胶囊的强度及微囊化细胞的生长、代谢。     

保加利亚乳杆菌微胶囊化工艺研究

目的制备保加利亚乳杆菌微胶囊,提高菌株的酸、热耐受性及降低菌体的分离成本。方法以保加利亚乳杆菌(Lactobacillus bulgaricus)为研究对象,海藻酸钠(SA)为壳材、CaCl2为固化剂,制备保加利亚乳杆菌微胶囊;包埋率、颗粒平均化程度、机械强度等为考核指标,研究保加利亚乳杆菌微胶囊化的工艺。结果当海藻酸钠浓度为0.75%、CaCl2浓度为3%、电压为600V、泵速为1.96mL/min、震动频率为80Hz时,微胶囊化包埋效果最佳,经固定化后的菌微胶囊保持了良好的保加利亚乳杆菌的活性,微囊化保加利亚乳杆菌经过2次连续发酵后的产酸量分别达到59.4g/L和55.8g/L。结论本研究为工业化生产乳酸提供了一条具有经济价值的途径。     

乙基纤维素微胶囊对过氧化氢酶固定化的研究

以乙基纤维素作模材,用液中干燥法使过氧化氢酶微胶囊化,研究了微胶囊化操作条件对酶活性影响。通过测定微胶囊化酶的释放曲线,证明微胶囊膜对过氧化氢酶具有较好的固定性能力,固定化酶用于催化底物过氧化氢分解,测定米氏常数为０．５５ｍｏｌ／Ｌ。     

静电喷雾法制备乳酸菌微胶囊的实验研究

目的为解决乳酸菌产品活菌数的不稳定性,对乳酸菌进行微胶囊化包埋。方法用海藻酸钠和明胶的混合体系作为壁材,对乳酸菌进行静电喷雾包埋处理,并让微胶囊化乳酸菌在模拟胃肠液的环境中进行耐酸性和肠溶性实验。结果混合体系的壁材与乳酸菌具有较好的生物相容性,优选得出当芯壁材为12时包埋率最高（96．3％）,微胶囊化乳酸菌在经人工胃液处理2h后,活菌数比未经微胶囊化的对照组高出2个数量级,且在经人工肠液处理40min后,乳酸菌几乎全部释放。结论静电喷雾法制备的乳酸菌微胶囊具有一定耐酸性和肠溶性。     

以阿拉伯胶为主要壁材的九头狮子草红色素微胶囊化色素液稳定性的比较研究

本文研究了阿拉伯胶为主要壁材,阿拉伯与蔗糖为复翕才的九狮子草红色素的微囊化方法,并对微囊红色素液的物理和化学稳定性进行了探讨。结果表明,以要拉伯胶与蔗糖配比为２Ｌ：１８的微囊化色素液理化性质较稳定。为九了草红以纱应用于食品生产及微囊化技术中壁材的选择提供了理论依据。     

紫玉米花青素的微胶囊化研究

花青素作为植物界广泛存在的一种天然食用色素,安全、无毒、资源丰富,而且具有一定营养和药理作用,然而花青素对pH值、氧气、温度、光、金属离子等十分敏感。拟利用微胶囊化技术,保护花青素的抗氧化特性,并比较了2种常用的微胶囊方法（喷雾干燥法和锐孔法）的包埋效果,以期为花青素的使用提供一定参考。结果表明,啧雾干燥法制备紫玉米花青素微胶囊效果较锐孔法更好,而且当选择麦芽糊精和阿拉伯胶1：1作喷雾干燥的壁材,芯材（花青素）与壁材按1：16制备时,其包埋率可达34％,效果最佳。     

乙基纤维素微胶囊对过氧化氢酶固定化的研究

以乙基纤维素作膜材,用液中干燥法使过氧化氢酶微胶囊化。研究了微胶囊化操作条件对酶活性的影响。通过测定微胶囊化酶的释放曲线,证明微胶囊膜对过氧化氢酶具有较好的固定性能力。固定化酶用于催化底物过氧化氢分解,测定米氏常数为０．５５ｍｏｌ／Ｌ。     

Yeast Cell Microcapsules as a Novel Carrier for Cholecalciferol Encapsulation: Development,Characterization and Release Properties

In this study Saccharomyces cerevisiae yeast cells was used as a novel vehicle for encapsulation of vitamin D₃. The effects of initial cholecalciferol concentration (100,000 and 500,000 IU/g yeast), yeast cell pretreatment (plasmolysis with NaCl) and drying method (spray or freeze drying) on microcapsules properties were investigated. It was found that the vitamin concentration and drying method had significant influence on encapsulation efficiency (EE) and size of yeast microcapsules. Furthermore, EE values were more increased by the plasmolysis treatment. The highest EE was obtained for plasmolysed and spray dried yeast cells prepared using initial cholecalciferol concentration of 2.5 mg per gram of yeast cells (76.10?±?6.92%). The values of mean particle size were 3.43–7.91 μm. The presence of cholecalciferol in yeast microcapsules was confirmed by X-ray diffraction (XRD) and Fourier transform-infrared (FT-IR) analyses. The in vitro cholecalciferol release from yeast microcapsules in phosphate buffer saline solution (PBS) followed a controlled release manner consistent with a Fickian diffusion mechanism. In addition, the release studies in simulated gastrointestinal tract showed sustained release of cholecalciferol in the stomach condition and significant release in intestinal medium.     

Cell encapsulation with alginate and alpha-phenoxycinnamylidene-acetylated poly(allylamine)

In general, microcapsules prepared from alginate and polycations lack mechanical strength because the interaction between alginate and polycations is ionic instead of covalent, which represents a much stronger bond. To increase the mechanical strength of the capsule, we prepared photosensitive microcapsules that could form covalent bonds between polymers in the capsular membrane by light irradiation. Two types of photosensitive poly(allylamine), with 5% and 10% of amino groups modified by alpha-phenoxycinnamylidene acetylchloride, were synthesized. Both photopolymers exhibited an absorption maximum at 325 nm and were capable of crosslinking upon light exposure. These photosensitive polymers were used for the preparation of microcapsules. The capsules formed from this photosensitive poly(allylamine) and alginate were strengthened significantly by light irradiation. Only 28% of the microcapsules prepared from the 5%-modified photopolymer fractured after 48 h of shaking at 150 rpm. This fracture percentage is much lower when compared with the 60% of capsules fractured when prepared from the untreated poly(allylamine). By using poly(allylamine) at 10% modification, the mechanical strength was improved only slightly, with 26% of capsules fractured. Analysis of the permeability test indicated that the photo-crosslinked capsular membrane was freely permeable to cytochrome c and myoglobin, but less permeable to serum albumin. The encapsulation method was used to entrap and culture IW32 mouse leukemia cells. The cells proliferated to a density of about 1.1 x 10(7) cells/mL in the capsules after 7 days of cultivation. Concurrently, the concentration of erythropoietin in the microcapsules increased to 800 mU/mL. This new encapsulation technique has great potential in the application of a bioindustrial cell-culturing process.     

Encapsulation of basic fibroblast growth factor by polyelectrolyte multilayer microcapsules and its controlled release for enhancing cell proliferation

Basic fibroblast growth factor (FGF2) is an important protein for cellular activity and highly vulnerable to environmental conditions. FGF2 protected by heparin and bovine serum albumin was loaded into the microcapsules by a coprecipitation-based layer-by-layer encapsulation method. Low cytotoxic and biodegradable polyelectrolytes dextran sulfate and poly-L-arginine were used for capsule shell assembly. The shell thickness-dependent encapsulation efficiency was measured by enzyme-linked immunosorbent assay. A maximum encapsulation efficiency of 42% could be achieved by microcapsules with a shell thickness of 14 layers. The effects of microcapsule concentration and shell thickness on cytotoxicity, FGF2 release kinetics, and L929 cell proliferation were evaluated in vitro. The advantage of using microcapsules as the carrier for FGF2 controlled release for enhancing L929 cell proliferation was analyzed.     

Growth of recombinant fibroblasts in alginate microcapsules

To develop a novel strategy of nonautologous somatic gene therapy, we now demonstrate the feasibility of culturing genetically modified fibroblasts within an immunoprotective environment and the optimal conditions required for their continued survival in vitro. When mouse Ltk(-) fibroblasts transfected with the human growth hormone gene were enclosed within permselective microcapsules fabricated from alginate-polylysine-alginate, they continued to secrete human growth hormone at the same rates as the nonencapsulated cells. They also continued to proliferate in vitro for at least 1 month even though their viability gradually declined to about 50%. The viability can be improved by controlling for (a) temperature during encapsulation, (b) duration of treatment with polylysine, (c) duration of liquefying the core alginate with sodium citrate, and (d) cell density at the time of encapsulation. The best conditions leading to improved survival and maximum proliferation of cells within the microcapsules were obtained by encapsulating the cells at 4 to 10 degrees C instead of room temperature, coating the microspheres with polylysine for 6 to 10 min instead of 20 min, liquefying the core alginate by treating with citrate for 20 min instead of 6 to 10 min, and using a concentration of 2 x 10(6) cells/mL of alginate for encapsulation. Under such conditions, normally adherent and genetically engineered mouse fibroblasts survived and proliferated optimally within the microcapsule environment. The encapsulated fibroblasts maintained their level of transgene expression while recombinant gene products such as human growth hormone could diffuse through the microcapsule membrane without impediment. The demonstration that genetically modified fibroblasts can survive and continue to deliver recombinant gene products from within these microcapsules and the optimization for their maximal viability and growth within microcapsules should increase the potential for success in using such microencapsulated recombinant cells for somatic gene therapy. (c) 1994 John Wiley & Sons, Inc.     

膜材与制备过程对血红蛋白微胶囊粒径和包埋率的影响

以单甲氧基聚乙二醇聚乳酸共聚物（PELA）为膜材用复乳溶剂扩散法制备了包含牛血红蛋白（BHb）的微胶囊,微胶囊中BHb的P₅₀和Hill系数分别为3 466 Pa和2.4左右,接近于天然BHb的生物活性。研究发现膜材种类对BHb微胶囊包埋率和粒径的影响最大,使用MPEG2000为亲水性嵌段的PELA共聚物时,包埋率最高,达到90％以上,粒径为3～5 μm左右;随着膜材浓度的增大,微胶囊包埋率和粒径均增加;随着外水相NaCl浓度的增大,微胶囊包埋率升高、粒径减小;随着外水相稳定剂PVA浓度的增大,微胶囊粒径减小,包埋率先升高后降低,在较低浓度下（10 g/L、20 g/L）包埋率较高;初乳化搅拌速率的增大,有利于包埋率的提高,但对粒径影响不大;复乳化搅拌速率的影响较复杂,当复乳液体积较大时,复乳化搅拌速率对微胶囊制备的影响规律性不明显。当固定膜材和初乳化搅拌速率时,包埋率和粒径之间存在着类似抛物线的关系,包埋率随着粒径的减小而降低。     

Metabolic activity of CHO fibroblasts in HEMA-MMA microcapsules

Chinese hamster ovary (CHO) fibroblast cells were microencapsulated in polyacrylate membranes (HEMA-MMA: 75% HEMA) via an interfacial precipitation process. The CHO cells were observed to grow in large aggregates, attached to each other instead of to the capsule wall. When CHO cells were encapsulated at high density (4 x 10(6) cells/mL), the initial metabolic activity in microcapsules, as determined by the MTT assay, correlated with the polymer-cell extrusion ratio, presumably because of the dependence of encapsulation efficiency on the relative flow rates. However, there was a large variation in the metabolic activity among individual microcapsules throughout the present study. Capsules with low encapsulation efficiency (at a "seeding" density of 4 x 10(6) cells/mL) exhibited a rapid increase in the metabolic activity during the following week. When CHO cells were encapsulated at low density (4 x 10(5) cells/mL), there was only a small increase in the metabolic activity. Only a small fraction ( approximately 5%) of the capsules exhibited a high level of metabolic activity and 40% of the capsules exhibited undetectable metabolic activity even after 2 weeks. We conclude that CHO cells, which served as model cells, survive the encapsulation process and retain an active metabolic state once enclosed by the HEMA-MMA membranes. However, the resultant microcapsules are extremely heterogeneous in the amount of retained metabolic activity.     

Preparation and Characterization of Microcapsules Containing Squalene

Ethylcellulose microcapsules containing squalene were fabricated by a solvent evaporation method. The parameters of core/shell ratio, content of surfactant, encapsulation efficiency, and drug-loading rate of squalene were investigated; the Polysorbate-80 was used as surfactant in the external phase. The results showed that the optimal ethylcellulose microcapsules containing squalene were obtained with a surfactant concentration of 0.5 % and a core/shell ratio of 1:1. Under the optimal conditions, the entrapment efficiency and the drug-loading rate reached to 60.31?±?0.55 % and 32.76?±?0.30 %, respectively. The appearance and size of microcapsules were measured by scanning electron microscope and metallographic microscope. The microcapsules were spherical in shape and have a mean diameter of 103 μm.     

The Combined Usage of β-Cyclodextrin and Milk Proteins in Microencapsulation of Bifidobacterium bifidum BB-12

The present study aimed to determine the effects of combined usage of β-cyclodextrin with whey protein isolate and sodium caseinate on the microencapsulation of Bifidobacterium bifidum-BB12 by spray drying.

From the results, the highest count of B. bifidum was provided by whey protein isolate as 8.62 log CFU/g. The increasing concentration of β-cyclodextrin considerably increases gastric and intestinal resistance to B. bifidum cells. In the gastric and intestinal test, the highest protection was determined in whey protein isolate substituted with 10% β-cyclodextrin with reduction rates of 0.98 and 3.30%, respectively. Moreover, free cells did not survive in the same gastric conditions. The lowest hygroscopicity was determined in whey protein isolate as 8.57%. It must be noted that increasing β-cyclodextrin concentration in carrier material combination led to an increase in hygroscopicity of microcapsules. In general, substitution with β-cyclodextrin increased the particle size of microparticles, and microcapsules produced with whey protein isolate had a smaller size than that of sodium caseinate.

     

Production and evaluation of dry alginate-chitosan microcapsules as an enteric delivery vehicle for probiotic bacteria

This study investigates the production of alginate microcapsules, which have been coated with the polysaccharide chitosan, and evaluates some of their properties with the intention of improving the gastrointestinal viability of a probiotic ( Bifidobacterium breve ) by encapsulation in this system. The microcapsules were dried by a variety of methods, and the most suitable was chosen. The work described in this Article is the first report detailing the effects of drying on the properties of these microcapsules and the viability of the bacteria within relative to wet microcapsules. The pH range over which chitosan and alginate form polyelectrolyte complexes was explored by spectrophotometry, and this extended into swelling studies on the microcapsules over a range of pHs associated with the gastrointestinal tract. It was shown that chitosan stabilizes the alginate microcapsules at pHs above 3, extending the stability of the capsules under these conditions. The effect of chitosan exposure time on the coating thickness was investigated for the first time by confocal laser scanning microscopy, and its penetration into the alginate matrix was shown to be particularly slow. Coating with chitosan was found to increase the survival of B. breve in simulated gastric fluid as well as prolong its release upon exposure to intestinal pH.     

Process optimization for microencapsulation of probiotic yeasts

Background

Microencapsulation is a technique which improves the survival and viability of probiotics. We demonstrate encapsulation of five potential probiotic yeasts with alginate and gum as encapsulation matrices to improve their gastrointestinal transit.

Methods

Gum extracted from various cereals viz. rice, oats, barley, finger millet and pearl millet along with alginate have been used to encapsulate five potential probiotic yeasts. Screening was carried out by measuring swelling index, encapsulation efficiency and nutritional value of microcapsules encapsulated with alginate and gum. The concentration of OBG, sodium alginate and inoculum dosage of probiotic yeasts was optimized using response surface methodology (RSM). Efficiency of alginate OBG microcapsules with or without coating materials viz. whey protein and chitosan also tested. The mucoadhesion ability and storage stability of alginate OBG microcapsules with coating materials were tested.

Results

Highest encapsulation efficiency of probiotic yeasts was noted using oats bran gum (OBG) microcapsules along with alginate in all the five probiotic yeasts. Notably whey protein coated microcapsules showed maximum GIT tolerance (95%) and mucoadhesion (90%) for L. starkeyi VIT-MN03. The minimum loss of viability was observed in L. starkeyi VITMN03 microcapsules on 60th day of storage.

Conclusions

This is the first report on optimization and survival of microencapsulated probiotic yeasts under simulated GIT conditions using natural gum and alginate as encapsulation matrices and whey protein as coating material.